Erasmus Shalihaxwe
To address one of its main challenges, the Namibia Institute of Pathology (NIP) has added 18 more vehicles to its fleet to meet specimen transportation needs.
The company announced last week that the addition of new vehicles is a significant milestone for its laboratories across the country, and it represents the ongoing commitment to invest in resources that will enable the organisation to deliver exceptional care to patients and healthcare partners in both the public and private industries.
The acquisition of new cars will also reduce waiting times and increase efficiency by ensuring samples are picked up from collection sites and transported safely to the nearest laboratory.
NIP Chief Executive Officer Kapena Tjombonde, during the announcement also highlighted that the investment not only demonstrates the NIP’s unwavering dedication to meeting the needs of stakeholders but also serves as a clear signal of its commitment to operational excellence and continuous improvement. Moreover, the initiative underscores the leadership dedication at all levels to the transformation and steadfast determination in fulfilling the NIP’s mandate of uplifting the healthcare agenda in Namibia.
“With these new vehicles, we aim to streamline our specimen transportation process, reduce transit times, and uphold the integrity of all specimens during transit. Therefore, NIP recognises the critical importance of efficient and reliable specimen transportation in ensuring the timely and accurate delivery of healthcare services. The delivery of these new vehicles represents a proactive step in the NIP commitment to overcome operational challenges and deliver on its promise of excellence in healthcare support,” said Tjombonde.
She added that the institution is positioning itself to better serve the healthcare community and contribute to the overall improvement of healthcare delivery nationwide. Thus, this significant investment is a testament to the company’s unwavering commitment to enhancing its capabilities and ensuring that NIP remains at the forefront of the healthcare industry.
“We are confident that these new vehicles will not only address the challenges we have faced in specimen transportation but also significantly improve the efficiency and reliability of our services. As NIP moves forward, the team remains steadfast in its commitment to transparency, accountability, and stakeholder engagement. The dedication to fostering trust and confidence among NIP stakeholders is a top priority and the institution is grateful for the ongoing support and collaboration to achieve shared healthcare objectives,” stated Tjombonde.
